{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"1.280","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"2,412,706,775","primaryexch":"香港交易所","ric":"2160.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BL5B4N5","am":"7.49","iv":"","ew_strike":"","as":"1.240","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"1.230","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-09-28 00:06:03.0","lo52":"0.630","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"陳國明","underlying_ric":"2160.HK","hi52":"1.690","issuer_name":"微創心通醫療科技有限公司 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"1.240","mkt_cap":"2.99","f_aum_hkd":null,"ew_sub_per_to":"","ls":"1.240","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 其他醫療保健","ew_desc":null,"inception_date":"","nc":"-0.040","aum":"","issued_shares_class_B":null,"vo":"6.01","secondary_listing_flag":false,"listing_date":"2021年2月4日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"微創心通醫療科技有限公司 - B","nm_s":"心通醫療－Ｂ","sym":"2160","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"微創心通醫療科技有限公司是一家主要從事為醫生和患者提供治療結構性心臟病的全醫療方案的醫療器械公司。該公司的主營業務是從事結構性心臟病領域的經導管及手術解決方案的研發和商業化。該公司的產品管線包括經導管主動脈瓣植入術（TAVI）系列產品、AnchorMan左心耳封堵器（LAAC）產品、經導管二尖瓣（TMV）產品、經導管三尖瓣（TTV）產品和手術配套產品。該公司在國內和國外市場開展業務。","op":"1.280","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"醫療設備及用品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>希慎道33號<br/>利園一期<br/>19樓1901室","pc":"-3.13","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"1.280","isin":"KYG6082P1054","moneyness":""}},"qid":"1759074413182"}
